Bipolar disorder: historic perspective, current pharmacologic treatment options and a review of quetiapine

References

• Abraham K. Notes on the psychoanalytical investigation and treatment of manic-depressive insanity and allied conditions. In: Selected Papers of Karl Abraham, MD Jones E (Ed.). Hogarth Press, London, UK (Original work published 1911) (1927).
   Google Scholar
• Burton R. In: The Anatomy of Melancholy. Faulkner TC, Kiessling NK, Blair RL (Eds). The Clarendon Press/Oxford University Press, Oxford, UK(1989–1994).
   Google Scholar
• Angst J, Sellaro R. Historical perspectives and natural history of bipolar disorder. Biol. Psychiatry 48(6), 445–457 (2000).
   PubMed Web of Science ®Google Scholar
• Des hallucinations, des causes qui les produisent et des maladies caractérisent. Mémoires de l’Académie de médecine (1842).
   Google Scholar
• Kleist K. Brain and psyche. J. Nerv. Ment. Dis. 116(6), 776–782 (1952).
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. DSM-I Diagnostic and Statistical Manual of Mental Disorders. First Edition. American Psychiatric Association, Washington, DC, USA (1952).
   Google Scholar
• American Psychiatric Association. DSM-III Diagnostic and Statistical Manual of Mental Disorders. Third Edition. American Psychiatric Association, Washington, DC, USA (1980).
   Google Scholar
• American Psychiatric Association. DSM-IV-TR Diagnostic and Statistical Manual of Mental Disorders. Fourth Edition, Text Revision. American Psychiatric Association, Washington, DC, USA (2000).
   Google Scholar
• Wozniak J. Recognizing and managing bipolar disorder in children. J. Clin. Psychiatry 66(Suppl. 1), 18–23 (2005).
   PubMedGoogle Scholar
• Tohen M, Goodwin F. Epidemiology of bipolar disorder. In: Psychiatric Epidemiology. Tsuang MT, Tohen M, Zahner G (Eds.). John Wiley and Sons, NY, USA, 301–316 (1995).
   Google Scholar
• Bowden CL. Update on bipolar disorder: epidemiology, etiology, diagnosis, and prognosis. Medscape Mental Health 2, 6 (1997).
   Google Scholar
• Lish JD, Dime-Meenan S, Whybrow PC, Price RA, Hirschfeld RM. The National Depressive and Manic-Depressive Association (DMDA) survey of bipolar members. J. Affect. Disord. 31(4), 281–294 (1994).
   PubMed Web of Science ®Google Scholar
• Bowring MA, Kovacs M. Difficulties in diagnosing manic disorders among children and adolescents. J. Am. Acad. Child Adolesc. Psychiatry 31(4), 611–614 (1992).
   PubMed Web of Science ®Google Scholar
• Borchardt CM, Bernstein GA. Comorbid disorders in hospitalized bipolar adolescents compared with unipolar depressed adolescents. Child Psychiatry Hum. Dev. 26(1), 11–18 (1995).
   PubMed Web of Science ®Google Scholar
• Benazzi F. Highly recurrent unipolar may be related to bipolar II. Compr. Psychiatry 43(4), 263–268 (2002).
   PubMed Web of Science ®Google Scholar
• Berrettini WH, Ferraro TN, Goldin LR et al. Chromosone 18 DNA markers and manic-depressive illness: evidence for a susceptibility gene. Proc. Natl Acad. Sci. USA 91(13), 5918–5921 (1994).
   PubMed Web of Science ®Google Scholar
• Calabrese JR, Hirschfeld RM, Frye MA, Reed ML. Impact of depressive symptoms compared with manic symptoms in bipolar disorder: results of a US community-based sample. J. Clin. Psychiatry 65(11), 1499–1504 (2004).
   PubMed Web of Science ®Google Scholar
• Tondo L, Baldessarini RJ, Hennen J, Floris G. Lithium maintenance treatment of depression and mania in bipolar I and bipolar II disorders. Am. J. Psychiatry 155(5), 638–645 (1998).
   PubMed Web of Science ®Google Scholar
• Goodwin FK, Jamison KR. In: Manic-Depressive Illness. Oxford University Press, NY, USA (1990).
   Google Scholar
• Akiskal HS, Bourgeois ML, Angst J, Post R, Moller H, Hirschfeld R. Re-evaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disorders. J. Affect. Disord. 59(Suppl. 1), 5–30 (2000).
   PubMed Web of Science ®Google Scholar
• Sachs GS, Thase ME. Bipolar disorder therapeutics: maintenance treatment. Biol. Psychiatry 48(6), 573–581 (2000).
   PubMed Web of Science ®Google Scholar
• Weisler, RH, Kalali AH, Ketter TA for the SPD417 Study Group. A multicenter, randomized, double-blind, placebo-controlled trial of extended-release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes. J. Clin. Psychiatry 65(4), 478–484 (2004).
   PubMed Web of Science ®Google Scholar
• Fung J, Mok H, Yatham LN. Lamotrigine for bipolar disorder: translating research into clinical practice. Expert Rev. Neurother. 4(3), 363–370 (2004).
   PubMedGoogle Scholar
• Muzina DJ, Elhaj O, Gajwani P, Gao K, Calabrese JR. Lamotrigine and anti-epileptic drugs as mood stabilizers in bipolar disorder. Acta Psychiatr. Scand. 426(Suppl.), 21–28 (2005).
   Google Scholar
• Amsterdam JD, Shults J, Brunswick DJ, Hundert M. Short-term fluoxetine monotherapy for bipolar Type II or bipolar NOS major depression - low manic switch rate. Bipolar Disord. 6(1), 75–81 (2004).
   PubMed Web of Science ®Google Scholar
• Masand P, Mago R. Review: in people with bipolar disorder, short-term antidepressants improve clinical response, although tricyclics risk inducing mania. Evid. Based Ment. Health 8(2), 35 (2005).
   PubMedGoogle Scholar
• Curtin F, Schulz P. Clonazepam and lorazepam in acute mania: a Bayesian meta-analysis. J. Affect. Disord. 78(3), 201–208 (2004).
   PubMed Web of Science ®Google Scholar
• Yingling DR, Utter G, Vengalil S, Mason B. Calcium channel blocker, nimodipine, for the treatment of bipolar disorder during pregnancy. Am. J. Obstet. Gynecol. 187(6), 1711–1712 (2002).
   PubMed Web of Science ®Google Scholar
• Pazzaglia PJ, Post RM, Ketter TA et al. Nimodipine monotherapy and carbamazepine augmentation in patients with refractory recurrent affective illness. J. Clin. Psychopharmacol. 18(5), 404–413 (1998).
   PubMed Web of Science ®Google Scholar
• Bech P. The Bech-Rafaelsen Mania Scale in clinical trials of therapies for bipolar disorder: a 20-year review of its use as an outcome measure. CNS Drugs 16(1), 47–63 (2002).
   Google Scholar
• Yatham LN. Atypical antipsychotics for bipolar disorder. Psychiatr. Clin. North Am. 28(2), 325–347 (2005).
   PubMed Web of Science ®Google Scholar
• Lorenzo RD, Genedani S. Atypical antipsychotics in the therapy of bipolar disorders: efficacy and safety. Expert Rev. Neurother. 2, 363–367 (2002).
   PubMedGoogle Scholar
• Fehr BS, Ozcan ME, Suppes T. Low doses of clozapine may stabilize treatment-resistant bipolar patients. Eur. Arch. Psychiatry Clin. Neurosci. 255(1), 10–14 (2005).
   PubMed Web of Science ®Google Scholar
• Lieberman DZ, Goodwin FK. Use of olanzapine in the treatment of bipolar I disorder. Expert Rev. Neurother. 4(5), 759–767 (2004).
   PubMedGoogle Scholar
• Sajatovic M, Madhusoodanan S, Fuller MA, Aulakh L, Keaton DB. Risperidone for bipolar disorders. Expert Rev. Neurother.. 5(2), 177–187 (2005).
   PubMedGoogle Scholar
• Keck PE Jr, Versiani M, Potkin S, West SA, Giller E, Ice K. Ziprasidone in Mania Study Group. Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial. Am. J. Psychiatry 160(4), 741–748 (2003).
   PubMed Web of Science ®Google Scholar
• Buckley PF. Second-generation antipsychotic medications in the treatment of mood disorders: focus on aripiprazole. Drugs Today 41(1), 5–11 (2005).
   PubMed Web of Science ®Google Scholar
• Product Information: Seroquel®, quetiapine. AstraZeneca Pharmaceuticals, Wilmington, DE reviewed 3/2004. (2004).
   Google Scholar
• Caley CF, Rosenbaum S. Focus on quetiapine: the fourth atypical antipsychotic. Formulary 33(2), 105–119 (1998).
   Google Scholar
• Casey D. ‘Seroquel’ (quetiapine): preclinical and clinical findings of a new atypical antipsychotic. Exp. Opin. Invest. Drugs 5, 939–957 (1996).
   Google Scholar
• Garver DL. Review of quetiapine side effects. J. Clin. Psychiatry 61(Suppl. 8), 31–33 (2000).
   PubMed Web of Science ®Google Scholar
• Goldstein JM, Litwin LC, Sutton EB, Malick JB. Seroquel: electrophysiological profile of a potential atypical antipsychotic. Psychopharmacology 112( 2–3), 293–298 (1993).
   Google Scholar
• Goren JL, Levin GM. Quetiapine, an atypical antipsychotic. Pharmacotherapy 18(6), 1183–1194 (1998).
   PubMed Web of Science ®Google Scholar
• Green B. Focus on quetiapine. Curr. Med. Res. Opin.. 15(3), 145–151 (1999).
   PubMed Web of Science ®Google Scholar
• Small JG, Hirsch SR, Arvanitis LA, Miller BG, Link CG. Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group. Arch. Gen. Psychiatry 54(6), 549–557 (1997).
   PubMed Web of Science ®Google Scholar
• Hirsch SR, Link CGG, Goldstein JM, Arvanitis LA. ICI 204,636: a new atypical antipsychotic drug. Br. J. Psychiatry 168(Suppl. 29), 45–46 (1996).
   Web of Science ®Google Scholar
• Swerdlow NR, Zisook D, Taaid N. Seroquel (ICI 204,636) restores prepulse inhibition of acoustic startle in apomorphine-treated rats: similarities to clozapine. Psychopharmacology 114(4), 675–678 (1994).
   PubMed Web of Science ®Google Scholar
• Knoth RL, Chen K, Tafesse E. Datapoints: costs associated with the treatment of patients with bipolar disorder in a managed care organization. Psychiatr. Serv. 55(12), 1353 (2004).
   PubMed Web of Science ®Google Scholar
• Sajatovic M, Blow FC, Ignacio RV, Kales HC. Age-related modifiers of clinical presentation and health service use among veterans with bipolar disorder. Psychiatr. Serv. 55(9), 1014–1021 (2004). Erratum in: Psychiatr. Serv. 55(12), 1442 (2004).
   PubMed Web of Science ®Google Scholar
• McIntyre RS, Brecher M, Paulsson B, Huizar K, Mullen J. Quetiapine or haloperidol as monotherapy for bipolar mania - a 12-week, double-blind, randomised, parallel-group, placebo-controlled trial. Eur. Neuropsychopharmacol. 15(5), 573–585 (2005).
   PubMed Web of Science ®Google Scholar
• Sachs G, Chengappa KN, Suppes T et al. Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study. Bipolar Disord. 6(3), 213–223 (2004).
   PubMed Web of Science ®Google Scholar
• Yatham LN, Paulsson B, Mullen J et al. Quetiapine versus placebo in combination with lithium or divalproex for the treatment of bipolar mania. J. Clin. Psychopharmacol. 24(6), 599–606 (2004).
   PubMed Web of Science ®Google Scholar
• Gill T, Khouzam HR, Tan DT. E-FALCONS. A mnemonic for monitoring the prescribing of atypical antipsychotics. Geriatrics 59(8), 41–42, 45 (2004).
   PubMedGoogle Scholar
• Vieta E, Mullen J, Brecher M et al. Quetiapine monotherapy for mania associated with bipolar disorder: combined analysis of two international, double-blind, randomised, placebo-controlled studies. Curr. Med. Res. 21(No. 6), 923–934 (2005).
   PubMed Web of Science ®Google Scholar
• Sajatovic M, Brescan DW, Perez DE et al. Quetiapine alone and added to a mood stabilizer for serious mood disorders. J. Clin. Psychiatry 62(9), 728–732 (2001).
   PubMed Web of Science ®Google Scholar
• Suppes T, McElroy SL, Keck PE et al. Use of quetiapine in bipolar disorder: a case series with prospective evaluation. Int. Clin. Psychopharmacol. 19(3), 173–174 (2004).
   PubMed Web of Science ®Google Scholar
• Hardoy MC, Garofalo A, Carpiniello B, Calabrese JR, Carta MG. Combination quetiapine therapy in the long-term treatment of patients with bipolar I disorder. Clin. Pract. Epidemol. Ment. Health 18, 1–7 (2005).
   Google Scholar
• Altamura AC, Salvadori D, Madaro D, Santini A, Mundo E. Efficacy and tolerability of quetiapine in the treatment of bipolar disorder: preliminary evidence from a 12-month open-label study. J. Affect. Disord. 76( 1–3), 267–271 (2003).
   PubMed Web of Science ®Google Scholar
• Sokolski KN, Denson TF. Adjunctive quetiapine in bipolar patients partially responsive to lithium or valproate. Prog. Neuropsychopharmacol. Biol. Psychiatry 27(5), 863–866 (2003).
   PubMed Web of Science ®Google Scholar
• Dunner DL, Fieve RR. Clinical factors in lithium carbonate prophylaxis failure. Arch. Gen. Psychiatry 30(2), 229–233 (1974).
   PubMed Web of Science ®Google Scholar
• Vieta E, Parramon G, Padrell E et al. Quetiapine in the treatment of rapid cycling bipolar disorder. Bipolar Disord. 4(5), 335–340 (2002).
   PubMed Web of Science ®Google Scholar
• Vieta E, Calabrese JR, Macfadden W, Minkwitz M, Mullen J. Quetiapine for the treatment of rapid-cycling bipolar depression. Poster presented at 13th Congress of the Association of European Psychiatrists, Munich, Germany, April 2–6 (2005).
   Google Scholar
• Post RM. The impact of bipolar depression. J. Clin. Psychiatry 66(Suppl. 5), 5–10 (2005).
   PubMed Web of Science ®Google Scholar
• Calabrese JR, Keck PE Jr, Macfadden W et al. A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. Am. J. Psychiatry 162(7), 1351–1360 (2005).
   PubMed Web of Science ®Google Scholar
• Sajatovic M, Madhusoodanan S, Coconcea N. Managing bipolar disorder in the elderly: defining the role of the newer agents. Drugs Aging 22(1), 39–54 (2005).
   PubMed Web of Science ®Google Scholar
• Sajatovic R, Calabrese JR, Mullen J. Quetiapine for the treatment of bipolar mania in older adults. Int. J. Geriatr. Psychiatry submitted (2005).
   Google Scholar
• Delbello MP, Schwiers ML, Rosenberg HL, Strakowski SM. A double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania. J. Am. Acad. Child Adolesc. Psychiatry 41(10), 1216–1223 (2002).
   PubMed Web of Science ®Google Scholar
• Marchand WR, Wirth L, Simon C. Quetiapine adjunctive and monotherapy for pediatric bipolar disorder: a retrospective chart review. J. Child Adolesc. Psychopharmacol. 14(3), 405–411 (2004).
   PubMed Web of Science ®Google Scholar
• Post RM, Leverich GS, Altshuler LL et al. An overview of recent findings of the Stanley Foundation Bipolar Network (Part I). Bipolar Disord. 5(5), 310–319 (2003).
   PubMed Web of Science ®Google Scholar
• Brown ES, Nejtek VA, Perantie DC, Bobadilla L. Quetiapine in bipolar disorder and cocaine dependence. Bipolar Disord. 4(6), 406–411 (2002).
   PubMed Web of Science ®Google Scholar
• Nakajima M, Terao T, Iwata N, Nakamura J. Switching female schizophrenic patients to quetiapine from conventional antipsychotic drugs: effects on hyperprolactinemia. Pharmacopsychiatry 38(1), 17–19 (2005).
   PubMed Web of Science ®Google Scholar
• Atmaca M, Kuloglu M, Tezcan E, Canatan H, Gecici O. Quetiapine is not associated with increase in prolactin secretion in contrast to haloperidol. Arch. Med. Res. 33(6), 562–565 (2002).
   PubMed Web of Science ®Google Scholar
• Petty RG. Prolactin and antipsychotic medications: mechanism of action. Schizophr Res. 35(Suppl.), 67–73 (1999).
   Google Scholar
• Shahzad S, Suleman MI, Shahab H et al. Cataract occurrence with antipsychotic drugs. Psychosomatics 43(5), 354–359 (2002).
   PubMed Web of Science ®Google Scholar
• Fraunfelder FW. Twice-yearly exams unnecessary for patients taking quetiapine. Am. J. Ophthalmol. 138(5), 870–871 (2004).
   PubMed Web of Science ®Google Scholar
• Hirsch SR, Link CGG, Goldstein JM, Arvanitis LA. ICI 204,636: a new atypical antipsychotic drug. Br. J. Psychiatry 168(Suppl. 29), 45–46 (1996).
   Web of Science ®Google Scholar
• Swerdlow NR, Zisook D, Taaid N. Seroquel (ICI 204,636) restores prepulse inhibition of acoustic startle in apomorphine-treated rats: similarities to clozapine. Psychopharmacology 114(4), 675–678 (1994).
   PubMed Web of Science ®Google Scholar
• Schotte A, Janssen PF, Gommeren W et al. Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding. Psychopharmacology 124(1–2), 57–73 (1996).
   PubMed Web of Science ®Google Scholar
• Cole P, Rabasseda X. Quetiapine in bipolar disorder: increasing evidence of efficacy and tolerability. Drugs Today 40(10), 837–852 (2004).
   PubMed Web of Science ®Google Scholar
• Bowden CL, Grunze H, Mullen J et al. A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder. J. Clin. Psychiatry 66(1), 111–121 (2001).
   Google Scholar
• Tarsy D, Baldessarini RJ, Tarazi FI. Effects of newer antipsychotics on extrapyramidal function. CNS Drugs 16, 23–45 (2002).
   PubMed Web of Science ®Google Scholar
• Lyseng-Williamson KA, Perry CM. Aripiprazole: in acute mania associated with bipolar I disorder. CNS Drugs 18, 367–376 (2004).
   PubMed Web of Science ®Google Scholar
• Nasrallah HA, Newcomer JW. Atypical antipsychotics and metabolic dysregulation: evaluating the risk/benefit equation and improving the standard of care. J. Clin. Psychopharmacol. 24(5 Suppl. 1), 7–14 (2004).
   PubMedGoogle Scholar
• Khouzam HR, Battista MA, Emes R, Ahles S Psychoses in late life: evaluation and management of disorders seen in primary care. Geriatrics 60(3), 26–33 (2005).
   PubMed Web of Science ®Google Scholar
• Jamison KR. Suicide and manic-depressive illness: an overview and personal account. In: The Harvard Medical School Guide to Suicide Assessment and Intervention. Jacobs DG (Ed.). Jossey-Bass, CA, USA, 251 (1999).
   Google Scholar